Kailera Therapeutics, Inc. (KLRA)
11.03
-0.30
(-2.65%)
USD |
NASDAQ |
Oct 13, 12:33
Kailera Therapeutics Debt to Equity Ratio : 0.0091 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0091 |
| Date | Value |
|---|---|
| March 31, 2026 | 0.0187 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Twist Bioscience Corp. | 0.21 |
| Prime Medicine, Inc. | 2.825 |
| GRAIL, Inc. | 0.0359 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.211B |
| Total Liabilities (Quarterly) | 92.95M |
| Shareholders Equity (Quarterly) | 1.118B |
| Current Ratio | 11.11 |